Emergence of a highly resistant Clostridium difficile strain (NAP/BI/027) in a tertiary care center in Saudi Arabia.
作者信息
Alzahrani Nabeel, Johani Sameera Al
出版信息
Ann Saudi Med. 2013 Mar-Apr;33(2):198-9. doi: 10.5144/0256-4947.2013.198.
Abstract
摘要
相似文献
1
Emergence of a highly resistant Clostridium difficile strain (NAP/BI/027) in a tertiary care center in Saudi Arabia.沙特阿拉伯一家三级医疗中心出现高耐药性艰难梭菌菌株（NAP/BI/027）。
Ann Saudi Med. 2013 Mar-Apr;33(2):198-9. doi: 10.5144/0256-4947.2013.198.
2
Continuing diarrhoea after ten days of oral metronidazole or oral vancomycin for presumed, hospital-acquired Clostridium difficile colitis in elderly hospital patients.对于老年住院患者疑似医院获得性艰难梭菌结肠炎，在口服甲硝唑或口服万古霉素治疗十天后仍持续腹泻。
J Hosp Infect. 2010 Apr;74(4):403-5. doi: 10.1016/j.jhin.2009.11.002. Epub 2010 Feb 12.
3
Two case reports of Clostridium difficile bacteremia, one with the epidemic NAP-1 strain.两例艰难梭菌菌血症病例报告，其中一例为流行的NAP-1 株。
Infection. 2011 Aug;39(4):371-3. doi: 10.1007/s15010-011-0115-7. Epub 2011 Apr 21.
4
Diagnostic approach to Clostridium difficile infection.艰难梭菌感染的诊断方法
Indian J Gastroenterol. 2010 Jul;29(4):137-9. doi: 10.1007/s12664-010-0038-8. Epub 2010 Aug 18.
5
Clostridium difficile infection.艰难梭菌感染
Clin Med (Lond). 2008 Oct;8(5):544-7. doi: 10.7861/clinmedicine.8-5-544.
6
Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain.由流行的艰难梭菌 BI 菌株引起的艰难梭菌感染的治愈率降低和复发率增加。
Clin Infect Dis. 2012 Aug;55(3):351-7. doi: 10.1093/cid/cis430. Epub 2012 Apr 20.
7
Defining the vulnerable period for re-establishment of Clostridium difficile colonization after treatment of C. difficile infection with oral vancomycin or metronidazole.定义口服万古霉素或甲硝唑治疗艰难梭菌感染后艰难梭菌定植再建立的脆弱期。
PLoS One. 2013 Oct 2;8(10):e76269. doi: 10.1371/journal.pone.0076269. eCollection 2013.
8
Clinical manifestations, treatment and control of infections caused by Clostridium difficile.艰难梭菌感染的临床表现、治疗与控制
Clin Microbiol Infect. 2005 Jul;11 Suppl 4:57-64. doi: 10.1111/j.1469-0691.2005.01165.x.
9
Clostridioides difficile infection: Incidence and risk factors in a tertiary care facility in Riyadh, Saudi Arabia.艰难梭菌感染：在沙特阿拉伯利雅得的一家三级保健机构的发生率和危险因素。
J Infect Public Health. 2020 Jul;13(7):1012-1017. doi: 10.1016/j.jiph.2019.10.014. Epub 2019 Dec 9.
10
Repurposing a platelet aggregation inhibitor ticagrelor as an antimicrobial against Clostridioides difficile.将血小板聚集抑制剂替卡格雷重新用作抗艰难梭菌的抗菌药物。
Sci Rep. 2020 Apr 16;10(1):6497. doi: 10.1038/s41598-020-63199-x.
引用本文的文献
1
Prevalence of toxigenic in hospitalized patients in the southwestern province of Saudi Arabia: Confirmation using the GeneXpert analysis.沙特阿拉伯西南部住院患者产毒 的流行情况：使用 GeneXpert 分析进行确认。
Libyan J Med. 2024 Dec 31;19(1):2294571. doi: 10.1080/19932820.2023.2294571. Epub 2023 Dec 19.
2
Clostridioides (Clostridium) difficile: A silent nosocomial pathogen.艰难梭菌（梭状芽孢杆菌）：一种沉默的医院病原体。
Saudi Med J. 2023 Sep;44(9):825-835. doi: 10.15537/smj.2023.44.9.20230216.
3
Systematic Review and Meta-Analysis on the Frequency of Antibiotic-Resistant Species in Saudi Arabia.沙特阿拉伯抗生素耐药菌频率的系统评价与荟萃分析
Antibiotics (Basel). 2022 Aug 29;11(9):1165. doi: 10.3390/antibiotics11091165.
4
An evaluation of toxigenic positivity as a patient outcome metric of antimicrobial stewardship in Saudi Arabia.评估产毒阳性作为沙特阿拉伯抗菌药物管理患者结局指标的情况。
J Infect Prev. 2021 Sep;22(5):231-236. doi: 10.1177/17571774211012780. Epub 2021 Jun 22.
5
infections in Saudi Arabia: Where are we standing?沙特阿拉伯的感染情况：我们目前处于什么状况？
Saudi Pharm J. 2020 Sep;28(9):1118-1121. doi: 10.1016/j.jsps.2020.07.013. Epub 2020 Aug 3.
6
Comparative Genome Analysis and Global Phylogeny of the Toxin Variant Clostridium difficile PCR Ribotype 017 Reveals the Evolution of Two Independent Sublineages.艰难梭菌毒素变异株PCR核糖体分型017的比较基因组分析及全球系统发育研究揭示了两个独立亚谱系的进化过程。
J Clin Microbiol. 2017 Mar;55(3):865-876. doi: 10.1128/JCM.01296-16. Epub 2016 Dec 28.
7
The First Two Clostridium difficile Ribotype 027/ST1 Isolates Identified in Beijing, China-an Emerging Problem or a Neglected Threat?在中国北京鉴定出的前两株艰难梭菌核糖体分型027/序列型1分离株——一个新出现的问题还是被忽视的威胁？
Sci Rep. 2016 Jan 7;6:18834. doi: 10.1038/srep18834.
8
Using a Novel Lysin To Help Control Clostridium difficile Infections.使用一种新型溶素来帮助控制艰难梭菌感染。
Antimicrob Agents Chemother. 2015 Dec;59(12):7447-57. doi: 10.1128/AAC.01357-15. Epub 2015 Sep 21.
本文引用的文献
1
Emergence of Clostridium difficile ribotype 027 in Korea.韩国艰难梭菌核糖型027的出现。
Korean J Lab Med. 2011 Jul;31(3):191-6. doi: 10.3343/kjlm.2011.31.3.191. Epub 2011 Jun 28.
2
Isolation of the first three cases of Clostridium difficile polymerase chain reaction ribotype 027 in Singapore.在新加坡分离出首例艰难梭菌聚合酶链反应 027 核糖型的三个病例。
Singapore Med J. 2011 May;52(5):361-4.
3
First isolation of Clostridium difficile 027 in Japan.日本首次分离出艰难梭菌027型。
Euro Surveill. 2007 Jan 11;12(1):E070111.3. doi: 10.2807/esw.12.02.03110-en.
4
Outbreak of Clostridium difficile infection in an English hospital linked to hypertoxin-producing strains in Canada and the US.英国一家医院发生艰难梭菌感染疫情，与加拿大和美国的高毒素产生菌株有关。
Euro Surveill. 2005 Jun 30;10(6):E050630.2. doi: 10.2807/esw.10.26.02735-en.
5
Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and Western Canada.来自加拿大东部和西部的艰难梭菌PCR核糖体分型027分离株的分子分析。
J Clin Microbiol. 2006 Jun;44(6):2147-52. doi: 10.1128/JCM.02563-05.
6
A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.艰难梭菌相关性腹泻的多机构主要克隆性暴发，发病率和死亡率高。
N Engl J Med. 2005 Dec 8;353(23):2442-9. doi: 10.1056/NEJMoa051639. Epub 2005 Dec 1.
Zotero 插件